Ignite Creation Date:
2024-05-06 @ 12:17 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01535989
Status:
COMPLETED
Last Update Posted:
2016-06-07
First Post:
2012-01-27
Brief Title:
Study of Inotuzumab Ozogamicin Temsirolimus in Patients With Relapsed or Refractory CD22 B-cell NHLymphoma
Sponsor:
Cristiana Sessa
Organization:
Oncology Institute of Southern Switzerland
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-27
First Submit QC Date:
February 17 2012
Study First Post Date:
2012-02-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-06
Last Update Post Date:
2016-06-07
Last Update Post Date Type:
ESTIMATED